Mitral stenosis is seen more commonly in women and in countries, generally developing nations, where rheumatic fever is common 1.
Patients with mitral stenosis characteristically present with progressive dyspnoea that is precipitated by sudden changes in heart rate, volume status or cardiac output (e.g. physical exertion, fever, emotional stress, anaemia, atrial fibrillation, pregnancy, etc.) 2,3. Clinical examination classically reveals a malar flush ('mitral facies') due to cutaneous vasoconstriction, and a mid-diastolic murmur that is heard on praecordial auscultation 2,3. Auscultation may also reveal an opening snap and a loud first heart sound 2,3.
Patients may also manifest symptoms from complications of mitral stenosis, such as haemoptysis from pulmonary venous hypertension, or Ortner syndrome from mass-effect of the large left atrium, or those of heart failure 2,3.
Mitral stenosis is usually acquired via rheumatic heart disease, where there is chronic inflammation of the mitral valve leaflets (mitral valvulitis) 2,3. This leads to progressive and diffuse fibrous thickening of the valve leaflets, and development of valvular calcifications 2,3. Eventually, the mitral commisures fuse and the chordae tendinae fuse 2,3. This culminates in significant immobilisation and narrowing of the mitral valve, giving it a characteristic 'fish mouth' appearance 2-4. Many patients will also have concurrent mitral regurgitation due to the valve being unable to sufficiently close 2,3.
The characteristic haemodynamic feature of mitral stenosis is an increased left atrial pressure 2,3. This increase in pressure is required as a compensatory mechanism for the stenosis, in order to maintain normal cardiac output 2,3. However, this compensation results in left atrial enlargement and an increase in pulmonary venous pressure 2,3. An increase in pulmonary venous pressure eventually leads to the development of pulmonary arterial hypertension, explaining why dyspnoea and haemoptysis are such prominent and important symptoms in mitral stenosis 2,3.
However, this adaptive mechanism eventually fails because as the left atrial pressure continues to increase as the stenosis worsens, the amount of time needed to fill the left ventricle with blood also increases 2,3. This can be compounded by atrial fibrillation, a complication of left atrial enlargement, which results in the loss of the 'atrial kick' at the end of diastole and an even greater left atrial pressure being needed 2,3.
This becomes particularly problematic if there is an increase in heart rate (i.e. aforementioned precipitants), because the diastolic period shortens more than the systolic period 2,3. This means there is even less time to fill the left ventricle, often resulting in a sudden drop in cardiac output and development of acute pulmonary oedema 2,3.
In addition to being a sequela of rheumatic fever, which is the most common cause world-wide, there are numerous other causes 2-4:
mitral annular calcification with leaflet involvement
- an age-related cause
- congenital mitral stenosis
- infective endocarditis
- cor triatriatum
- connective tissue disorders
- radiation-induced heart disease
- left atrial myxoma (generally not considered 'true' mitral stenosis)
- ball valve thrombus (generally not considered 'true' mitral stenosis)
Typical chest radiographic features include 2,4-6:
left atrial enlargement
- convexity or straightening of the left atrial appendage just below the main pulmonary artery (along left heart border)
- double density sign: the right side of the enlarged left atrium pushes into the adjacent lung and creates an addition contour superimposed over the right heart
- elevation of the left main bronchus and splaying of the carina
- walking man sign on lateral projections
- upper zone venous enlargement due to pulmonary venous hypertension
- pulmonary oedema
- diffuse alveolar haemorrhage
- secondary pulmonary haemosiderosis, often difficult to appreciate on a plain radiograph
- pulmonary ossification, a late sign
If the underlying aetiology is mitral annular calcification, then this may also be appreciated on plain film.
Echocardiography is useful for assessing the mitral valve area, jet velocity, pressure gradients, and the left ventricle 2,7. Various parameters are used in order to determine severity, such as 2,7:
- valve area >1.5 cm2
- mean gradient <5 mmHg
- pulmonary artery pressure <30 mmHg
- valve area 1.0-1.5 cm2
- mean gradient 5-10 mmHg
- pulmonary artery pressure 30-50 mmHg
- valve area <1.0 cm2
- mean gradient >10 mmHg
- pulmonary artery pressure >50 mmHg
Additionally, the mitral valve anatomy can be assessed 7. One widely adopted echocardiographic scoring system for this is one that Wilkins et al. developed. In this system, four features of the mitral valve are identified, as follows 7:
- valve leaflet mobility
- valve leaflet thickening
- valve leaflet calcification
- subvalvular thickening
Dynamic CT imaging
Rheumatic mitral stenosis may have distinctive morphological features on dynamic imaging 4. Restricted opening of the thickened valve from commissural fusion (especially with rheumatic valve disease), valve leaflet calcification, or both, results in a 'fish mouth' appearance on short-axis images 4. Bowing of a thickened and fibrotic anterior leaflet during diastole may result in a 'hockey-stick' appearance which is best seen on two- or four-chamber images 4.
On the other hand, non-rheumatic causes of mitral stenosis usually produce nonspecific imaging features such as valve thickening or leaflet fixation 4.
Cardiac MRI (CMR) is able to provide the most detailed structural and dynamic assessment of the mitral valve and left-sided cardiac chambers 8-10.
Observable features include 8-10:
- mitral leaflet thickening
- reduced diastolic opening
- abnormal valve motion toward the left ventricular outflow tract
Velocity-encoded cine-magnetic resonance imaging (VEC-MRI) is a relatively new method for quantitation of blood flow with the potential to measure high-velocity jets across stenotic valves 11.
Treatment and prognosis
The decision to treat mitral stenosis is based on the severity and presence of complications. Management involves a combination of lifestyle and pharmacotherapy measures (a similar armamentarium to that used in heart failure and atrial fibrillation), and mitral valve surgery (e.g. mitral valvotomy or mitral valve replacement) 12. Additionally, patients with rheumatic mitral stenosis may need penicillin prophylaxis to prevent recurrence 12.
Further details in regards to management is beyond the scope of this article.
- congestive heart failure
- pulmonary hypertension
- mass-effect from left atrial enlargement (e.g. Ortner syndrome, dysphagia megalatriensis)
- pulmonary embolus (often recurrent)
- pulmonary infections (e.g. pneumonia, bronchitis)
- atrial fibrillation
- sudden cardiac death from other arrhythmias
- thrmoboembolic ischaemic stroke, including from calcified cerebral embolism if the cause is mitral annular calcification
- mitral regurgitation
- tricuspid regurgitation
- valvular heart disease
- mitral valve disease
- general mitral valve pathologies:
- mitral valve stenosis
- mitral valve regurgitation
- specific mitral valve pathologies:
- 1. Movahed MR, Ahmadi-Kashani M, Kasravi B, Saito Y. Increased prevalence of mitral stenosis in women. (2006) Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 19 (7): 911-3. doi:10.1016/j.echo.2006.01.017 - Pubmed
- 2. Fauci AS. Harrison's principles of internal medicine. New York: McGraw-Hill, Medical Publishing Division; 2008.
- 3. Horstkotte D, Niehues R, Strauer BE. Pathomorphological aspects, aetiology and natural history of acquired mitral valve stenosis. (1991) European heart journal. 12 Suppl B: 55-60. Pubmed
- 4. Morris MF, Maleszewski JJ, Suri RM et-al. CT and MR imaging of the mitral valve: radiologic-pathologic correlation. Radiographics. 2010;30 (6): 1603-20. doi:10.1148/rg.306105518 - Pubmed citation
- 5. Hurst JW. Memories of patients with a giant left atrium. Circulation. 2001;104 (22): 2630-1. doi:10.1161/hc4701.100775 - Pubmed citation
- 6. Woolley K, Stark P. Pulmonary parenchymal manifestations of mitral valve disease. Radiographics. 1999;19 (4): 965-72. Radiographics (full text) - Pubmed citation
- 7. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quiñones M. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology. 10 (1): 1-25. doi:10.1093/ejechocard/jen303 - Pubmed
- 8. Park JH, Han MC, Oh BH et-al. Magnetic resonance evaluation of mitral stenosis. Cardiovasc Intervent Radiol. 13 (5): 294-9. - Pubmed citation
- 9. Heidenreich PA, Steffens J, Fujita N et-al. Evaluation of mitral stenosis with velocity-encoded cine-magnetic resonance imaging. Am. J. Cardiol. 1995;75 (5): 365-9. Am. J. Cardiol. (link) - Pubmed citation
- 10. Casolo GC, Zampa V, Rega L et-al. Evaluation of mitral stenosis by cine magnetic resonance imaging. Am. Heart J. 1992;123 (5): 1252-60. Am. Heart J. (link) - Pubmed citation
- 11. Hartiala JJ, Mostbeck GH, Foster E et-al. Velocity-encoded cine MRI in the evaluation of left ventricular diastolic function: measurement of mitral valve and pulmonary vein flow velocities and flow volume across the mitral valve. Am. Heart J. 1993;125 (4): 1054-66. - Pubmed citation
- 12. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM, Thomas JD. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) Circulation. 129 (23): 2440-92. doi:10.1161/CIR.0000000000000029 - Pubmed